What is AlloSource?
Founded in 1994 and based in Colorado, AlloSource is a nonprofit organization dedicated to the critical mission of improving patient outcomes through the use of allogeneic cells and tissue. The company serves surgeons by providing them with the necessary biological materials to perform life-changing procedures. AlloSource's commitment extends to advancing the scientific understanding and practical application of these transplantable materials, positioning it as a key player in the regenerative medicine and tissue engineering sectors.
How much funding has AlloSource raised?
AlloSource has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
Key Investors in AlloSource
PPP
Public-Private Partnership
What's next for AlloSource?
With a substantial enterprise-level funding round, AlloSource is poised for significant growth and expansion. The strategic investment will likely fuel further research and development initiatives, enhance operational capabilities, and broaden the reach of its life-saving allografts. Future endeavors may include exploring novel applications for cellular and tissue therapies, forging new partnerships within the healthcare ecosystem, and potentially expanding its geographical footprint to serve a wider patient population. The organization's nonprofit status suggests a focus on sustainable impact and patient welfare over profit maximization.
See full AlloSource company page
